214 related articles for article (PubMed ID: 26928832)
1. Refractory and/or Relapsing Cryptococcosis Associated with Acquired Immune Deficiency Syndrome: Clinical Features, Genotype, and Virulence Factors of Cryptococcus spp. Isolates.
Nascimento E; Vitali LH; Tonani L; Kress MR; Takayanagui OM; Martinez R
Am J Trop Med Hyg; 2016 May; 94(5):975-81. PubMed ID: 26928832
[TBL] [Abstract][Full Text] [Related]
2. Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
Vechi HT; Theodoro RC; de Oliveira AL; Gomes RMODS; Soares RDA; Freire MG; Bay MB
BMC Infect Dis; 2019 Mar; 19(1):220. PubMed ID: 30832607
[TBL] [Abstract][Full Text] [Related]
3. Cryptococcus neoformans and C. gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal disease.
Nascimento E; Vitali LH; Kress MRVZ; Martinez R
Rev Inst Med Trop Sao Paulo; 2017; 59():e49. PubMed ID: 28793019
[TBL] [Abstract][Full Text] [Related]
4. Disseminated cryptococcosis in an AIDS patient caused by a canavanine-resistant strain of Cryptococcus neoformans var. grubii.
Khan ZU; Al-Anezi AA; Chandy R; Xu J
J Med Microbiol; 2003 Mar; 52(Pt 3):271-275. PubMed ID: 12621094
[TBL] [Abstract][Full Text] [Related]
5. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility.
Liaw SJ; Wu HC; Hsueh PR
Clin Microbiol Infect; 2010 Jun; 16(6):696-703. PubMed ID: 19694765
[TBL] [Abstract][Full Text] [Related]
6. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole.
Agudelo CA; Muñoz C; Ramírez A; Tobón AM; de Bedout Bact C; Cano LE; Restrepo A
Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338
[TBL] [Abstract][Full Text] [Related]
7. Eyelid nodule: a sentinel lesion of disseminated cryptococcosis in a patient with acquired immunodeficiency syndrome.
Coccia L; Calista D; Boschini A
Arch Ophthalmol; 1999 Feb; 117(2):271-2. PubMed ID: 10037581
[No Abstract] [Full Text] [Related]
8. The epidemiology of cryptococcosis and the characterization of Cryptococcus neoformans isolated in a Brazilian University Hospital.
Aguiar PADF; Pedroso RDS; Borges AS; Moreira TA; Araújo LB; Röder DVDB
Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e13. PubMed ID: 28423088
[TBL] [Abstract][Full Text] [Related]
9. Molecular typing and in vitro antifungal susceptibility of Cryptococcus spp from patients in Midwest Brazil.
Favalessa OC; de Paula DA; Dutra V; Nakazato L; Tadano T; Lazera Mdos S; Wanke B; Trilles L; Walderez Szeszs M; Silva D; Hahn RC
J Infect Dev Ctries; 2014 Aug; 8(8):1037-43. PubMed ID: 25116671
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of antifungal combination against Cryptococcus spp.
Reichert-Lima F; Busso-Lopes AF; Lyra L; Peron IH; Taguchi H; Mikami Y; Kamei K; Moretti ML; Schreiber AZ
Mycoses; 2016 Sep; 59(9):585-93. PubMed ID: 27135278
[TBL] [Abstract][Full Text] [Related]
11. Current concepts in cryptococcosis.
Patterson TF; Andriole VT
Eur J Clin Microbiol Infect Dis; 1989 May; 8(5):457-65. PubMed ID: 2502410
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary coinfection by Pneumocystis jiroveci and Cryptococcus neoformans.
Javier B; Susana L; Santiago G; Alcides T
Asian Pac J Trop Biomed; 2012 Jan; 2(1):80-2. PubMed ID: 23569840
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous Pneumocystis carinii and Cryptococcus neoformans in AIDS.
Sandler B; Potter TS; Hashimoto K
Br J Dermatol; 1996 Jan; 134(1):159-63. PubMed ID: 8745906
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Hagen F; Hare Jensen R; Meis JF; Arendrup MC
Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
[TBL] [Abstract][Full Text] [Related]
15. [Cryptococcosis caused by Cryptococcus neoformans var. Gattii. A case associated with acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire].
Muyembe Tamfum JJ; Mupapa Kibadi D; Nganda L; Ngwala-Bikindu D; Kuezina T; Kela-We I; Vandepitte J
Med Trop (Mars); 1992; 52(4):435-8. PubMed ID: 1494313
[TBL] [Abstract][Full Text] [Related]
16. Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.
Mitchell TG; Perfect JR
Clin Microbiol Rev; 1995 Oct; 8(4):515-48. PubMed ID: 8665468
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of Cryptococcus neoformans in faeces of an AIDS patient].
Madueño A; Hernandez-Porto M; Alonso Socas MM; Lecuona M
Rev Esp Quimioter; 2017 Apr; 30(2):140-141. PubMed ID: 28198172
[No Abstract] [Full Text] [Related]
18. Epidemiology of Cryptococcus and cryptococcosis in China.
Fang W; Fa Z; Liao W
Fungal Genet Biol; 2015 May; 78():7-15. PubMed ID: 25445309
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization and evaluation of virulence factors of Cryptococcus laurentii and Cryptococcus neoformans strains isolated from external hospital areas.
Andrade-Silva L; Ferreira-Paim K; Silva-Vergara ML; Pedrosa AL
Fungal Biol; 2010; 114(5-6):438-45. PubMed ID: 20943154
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy of cryptococcosis.
Ritter M; Goldman DL
Expert Opin Pharmacother; 2009 Oct; 10(15):2433-43. PubMed ID: 19708853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
